HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Saltis Selected Research

23,24-dihydrocucurbitacin F

9/2012Anti-proliferative effect of 23,24-dihydrocucurbitacin F on human prostate cancer cells through induction of actin aggregation and cofilin-actin rod formation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Saltis Research Topics

Disease

2Prostatic Neoplasms (Prostate Cancer)
09/2012 - 09/2011
1Bacillary Dysentery (Shigellosis)
09/2012
1Gastroenteritis
09/2012
1Neoplasms (Cancer)
09/2012
1Hypoxia (Hypoxemia)
09/2011
1Hemophilia A (Haemophilia)
10/2010
1Genomic Instability
02/2006

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
09/2011 - 10/2010
123,24-dihydrocucurbitacin FIBA
09/2012
1Actin Depolymerizing Factors (Cofilins)IBA
09/2012
1CucurbitacinsIBA
09/2012
1Histones (Histone)IBA
09/2011
1Valproic Acid (Depakote)FDA LinkGeneric
09/2011
1Histone Deacetylase InhibitorsIBA
09/2011
1GossypolIBA
09/2011
1Blood Coagulation Factors (Coagulation Factor)IBA
10/2010
1AntibodiesIBA
02/2006

Therapy/Procedure

2Therapeutics
09/2011 - 10/2010
1Drug Therapy (Chemotherapy)
09/2011
1Intravenous Administration
10/2010